Medite Cancer Diagnostics, Inc. (CYOE) financial statements (2022 and earlier)

Company profile

Business Address 414 NORTH ORLEANS STREET
CHICAGO, IL 60610
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments73108587230139
Cash and cash equivalents73108587230139
Receivables4531,3461,7981,99110134
Inventory, net of allowances, customer advances and progress billings2,4033,8113,0753,415
Inventory2,4033,8113,0753,415  
Prepaid expense and other current assets10
Other undisclosed current assets535791861545 
Total current assets:3,4645,3445,6465,79016183
Noncurrent Assets
Property, plant and equipment1,7781,5571,9412,091579
Intangible assets, net (including goodwill)4,6584,6584,6582,453
Goodwill4,6584,6584,6582,453  
Other noncurrent assets196351273245 
Other undisclosed noncurrent assets5,8605,8605,8605,860  
Total noncurrent assets:12,49212,42612,73210,649579
TOTAL ASSETS:15,95617,77018,37816,43921262
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,2523,3063,0324,1344,5004,773
Accounts payable1,0041,093  311681
Accrued liabilities3,2523,3063,0323,178537903
Employee-related liabilities1,4151,335 2,0643,3242,705
Taxes payable    328484
Interest and dividends payable   445  
Other undisclosed accounts payable and accrued liabilities(2,419)(2,428) (1,553)  
Debt(50)(3,214)(2,857)2,5553670
Due to related parties15414670110853,175
Other undisclosed current liabilities4267,1095,916 (328)(484)
Total current liabilities:3,7827,3476,1616,7994,2937,534
Noncurrent Liabilities
Long-term debt and lease obligation4,869601211,209  
Long-term debt, excluding current maturities4,869601211,209  
Liabilities, other than long-term debt1,5302,3402,930   
Deferred tax liabilities, net1,4852,2052,205   
Due to related parties45135725   
Total noncurrent liabilities:6,3992,4003,0511,209  
Total liabilities:10,1819,7479,2128,0084,2937,534
Stockholders' equity
Stockholders' equity attributable to parent5,7758,0239,1668,431(4,272)(7,272)
Preferred stock9629629621,4871,4871,487
Common stock2923211927178
Treasury stock, value(327)(327)(327)(327)(327)(327)
Common stock, value, subscriptions 25  
Additional paid in capital13,7509,3668,3405,76397,13793,407
Accumulated other comprehensive loss(444)(642)(609)(149)  
Retained earnings (accumulated deficit)(8,195)(1,384)7791,638(102,840)(101,917)
Total stockholders' equity:5,7758,0239,1668,431(4,272)(7,272)
TOTAL LIABILITIES AND EQUITY:15,95617,77018,37816,43921262

Income statement (P&L) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
6,8139,2389,88710,98324198
Cost of revenue(6,651)(5,608)(6,084)(7,164)(8)(104)
Gross profit:1623,6303,8033,8191694
Operating expenses(1,481)(1,691)(1,455)(1,566)(908)(1,576)
Other undisclosed operating income (loss)(5,161)(3,600)(2,947)(2,647)74213
Operating loss:(6,480)(1,661)(599)(394)(818)(1,269)
Nonoperating expense(818)(634)(182)(201)(105)(245)
Other nonoperating income189602275  
Interest and debt expense(158)(20)(2) 117323
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes158202 (117)(323)
Loss from continuing operations before income taxes:(7,298)(2,295)(781)(595)(923)(1,514)
Income tax expense (benefit)487132(78)(104)  
Net loss attributable to parent:(6,811)(2,163)(859)(699)(923)(1,514)
Preferred stock dividends and other adjustments(91)(91)(78)(109)(266)(266)
Net loss available to common stockholders, diluted:(6,902)(2,254)(937)(808)(1,189)(1,780)

Comprehensive Income ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(6,811)(2,163)(859)(699)(923)(1,514)
Other comprehensive income (loss)198(33)(460)   
Comprehensive loss:(6,613)(2,196)(1,319)(699)(923)(1,514)
Other undisclosed comprehensive loss, net of tax, attributable to parent   (436)  
Comprehensive loss, net of tax, attributable to parent:(6,613)(2,196)(1,319)(1,135)(923)(1,514)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: